InvestSMART

Alcidion Group Limited (ASX:ALC)

ALERT: Price-sensitive ASX Announcement for ALC
Current share price for ALC : $0.095 -0.004 (-4.04%)+
Announcement
Release
8 Jan 2026 8:24AM
Price at Release
$0.099
Full Release
download
Summary
Alcidion Group Limited has been selected by University Hospitals Sussex NHS Foundation Trust (UHSx) as their preferred supplier for a new Electronic Patient Record (EPR) system. The selection came after a competitive tendering process and is set to result in a contract valued at over A$35 million for a minimum of seven years. Deployment of Alcidion's Miya Precision platform, including Miya Observations and Assessments, is slated to commence in the fourth quarter of the financial year 2026. This builds on Alcidion's long-standing relationship with UHSx, where its Patientrack solution is already in use. The EPR system is designed to facilitate real-time access to patient records, improve patient flow, and support clinical decision-making at UHSx, one of the largest acute trusts in the UK.
Key Points
  • Alcidion has been chosen by University Hospitals Sussex NHS Foundation Trust (UHSx) as the preferred supplier for a new Electronic Patient Record (EPR) system.
  • The selection was made following a competitive tender process.
  • The expected Total Contract Value (TCV) is anticipated to exceed A$35 million over a minimum period of 7 years.
  • Deployment of Alcidion's Miya Precision platform is expected to begin in Q4 FY26, which includes Miya Observations and Assessments.
  • UHSx is a longstanding Alcidion customer, already utilizing the Patientrack solution.
  • The EPR system aims to provide real-time access to patient records, streamline patient flow, and enhance clinical decision-making.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.